Thyrotoxicosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
We report here a case of alemtuzumab-induced thyroid disease in a female patient who showed a phase of thyrotoxicosis with positive anti-thyroglobulin (anti-Tg) and anti-thyroid peroxidase (TPO) antibodies, but a negative TSH receptor antibody, spontaneously followed by hypothyroidism.
|
30968726 |
2019 |
Thyrotoxicosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
POSITIVE THYROTROPIN RECEPTOR ANTIBODIES IN PATIENTS WITH TRANSIENT THYROTOXICOSIS.
|
29624097 |
2018 |
Thyrotoxicosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
For four women, these goiters were secondary to fetal dyshormonogenesis, for 9 more to Graves disease with TSH receptor antibodies (TRAb), and for four women to thyrotoxicosis at the start of pregnancy, managed by synthetic antithyroid drugs (ATD).
|
30513035 |
2018 |
Thyrotoxicosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
We describe a 6-month-old boy with a de novo mutation in the TSHR gene who presented with accelerated growth, enlarging head circumference, tremor and thyrotoxicosis.
|
28195550 |
2017 |
Thyrotoxicosis
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Abnormal thyroid function studies and an elevated thyroid-stimulating hormone receptor antibody level confirmed the diagnosis of Graves thyrotoxicosis.
|
26181502 |
2017 |
Thyrotoxicosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Although rare, TSHR mutations should be considered in an infant presenting with thyrotoxicosis in absence of demonstrable TSHR antibodies in serum.
|
18558604 |
2009 |
Thyrotoxicosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, our data indicate that gain of function germline mutations in the TSHr gene should be investigated in families with members suffering from thyrotoxicosis and progressive growth of goiter, but without clinical and biochemical evidence of autoimmune thyroid disease.
|
18175146 |
2008 |
Thyrotoxicosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
A novel TSHR germline mutation (N372T) was found in a man who presented with thyrotoxicosis.
|
18466076 |
2008 |
Thyrotoxicosis
|
0.400 |
GeneticVariation
|
disease |
LHGDN |
A novel TSHR germline mutation (N372T) was found in a man who presented with thyrotoxicosis.
|
18466076 |
2008 |
Thyrotoxicosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Although the overall rate of thyrotoxicosis in the mice was < 10%, anti-TSH receptor antibodies could be detected in many animals by flow cytometry, radioreceptor assay, and functional bioassays using recombinant human TSH receptor.
|
17293446 |
2007 |
Thyrotoxicosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Prevalence of germline mutations in the TSH receptor gene as a cause of juvenile thyrotoxicosis.
|
15384882 |
2004 |
Thyrotoxicosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
A heterozygous germline mutation of the TSHR gene resulting in the substitution of serine (AGC) by asparagine (AAC) at codon 505 (S505N) was found, which co-segregated with thyrotoxicosis in the family.
|
15163335 |
2004 |
Thyrotoxicosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Clinical thyrotoxicosis is directly caused by autoantibodies that activate the thyrotropin receptor (TSHR).
|
12813025 |
2003 |
Thyrotoxicosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
A novel heterozygous germline mutation (ATG --> GTG; Met463Val) was identified in the second membrane spanning TSHR region in 6 relatives with thyrotoxicosis and goiter and absence of TSHR antibodies.
|
11201847 |
2000 |
Thyrotoxicosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
TSH-R mutation must be considered in early nonautoimmune thyrotoxicosis.
|
10095169 |
1999 |
Thyrotoxicosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
A germline mutation of the thyrotropin receptor gene associated with thyrotoxicosis and mitral valve prolapse in a Chinese family.
|
10199795 |
1999 |
Thyrotoxicosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
A novel thyrotropin receptor mutation in an infant with severe thyrotoxicosis.
|
10560955 |
1999 |
Thyrotoxicosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
A Val 677 activating mutation of the thyrotropin receptor in a Hürthle cell thyroid carcinoma associated with thyrotoxicosis.
|
10037070 |
1999 |
Thyrotoxicosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Activating mutations of TSH-R have been described in toxic nodules and more recently in familial nonautoimmune thyrotoxicosis.
|
9167947 |
1997 |
Thyrotoxicosis
|
0.400 |
Biomarker
|
disease |
CTD_human |
Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma.
|
9062474 |
1997 |
Thyrotoxicosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Nucleotide sequence analysis of PCR fragments corresponding to the TSH-receptor (TSHR) amplified from genomic DNA collected from the four members of a family, two of which had Graves' thyrotoxicosis, revealed a nucleotide substitution in the first position of codon 36 of the TSH-receptor gene in the two patients.
|
7556878 |
1995 |